Evidence map›Paper›PMID 39414673›Full record

ArticleInflammation2025

Exploration of Risk Factors for Cardiovascular Disease in Patients with Rheumatoid Arthritis: A Retrospective Study.

Min Feng, Fanxing Meng, Yuhan Jia, Yanlin Wang, Guozhen Ji, Chong Gao, Jing Luo

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Min FengDepartment of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Fanxing MengShanxi Medical University, Taiyuan, Shanxi, China.
Yuhan JiaShanxi Medical University, Taiyuan, Shanxi, China.
Yanlin WangDepartment of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Guozhen JiShanxi Medical University, Taiyuan, Shanxi, China.
Chong GaoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Jing LuoDepartment of Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. ljty966@hotmail.com.

Funding

the Foundation of Shanxi Key Laboratory for immunomicroecology 202104010910012the Project of Central Guides Local Science and Technology Development Funds YDZJSX2022C031the Research Project Supported by Shanxi Scholarship Council of China 2020-191the Science and Technology Innovation Project of Shanxi Province 2020SYS08the Scientifific research project of Shanxi Provincial Health Commission 2019044
6 · The paper itself

Abstract

objectivePatients with rheumatoid arthritis (RA) have increased mortality and morbidity rates owing to cardiovascular diseases (CVD). Timely detection of CVD in RA can greatly improve patient prognosis; however, this technique remains challenging. We aimed to investigate the risk factors for CVD incidence in patients with RA.

methodsThis retrospective study included RA patients without CVD risk factors (n = 402), RA with CVD risk factors (n = 394), and RA with CVD (n = 201). Their data on routine examination indicators, vascular endothelial growth factor (VEGF), and immune cells were obtained from medical records. The characteristic variables between each group were screened using univariate analysis, least absolute shrinkage and selection operator (LASSO), random forest (RF), and logistic regression (LR) models, and individualized nomograms were further established to more conveniently observe the likelihood of CVD in RA.

resultsUnivariate analysis revealed significantly elevated levels of white blood cells (WBC), blood urea nitrogen (BUN), creatinine, creatine kinase (CK), lactate dehydrogenase (LDH), VEGF, serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein (LDL), apolipoprotein B100 (ApoB100), and apolipoprotein E (ApoE) in RA patients with CVD, whereas apolipoprotein A1 (ApoA1) and high-density lipoprotein/cholesterol (HDL/TC) were decreased. Furthermore, the ratio of regulatory T (Treg) cells exhibiting excellent separation performance in RA patients with CVD was significantly lower than that in other groups, whereas the ratios of Th1/Th2/NK and Treg cells were significantly elevated. The LASSO, RF, and LR models were also used to identify the risk factors for CVD in patients with RA. Through the final selected indicators screened using the three machine learning models and univariate analysis, a convenient nomogram was established to observe the likelihood of CVD in patients with RA.

conclusionsSerum lipids, lipoproteins, and reduction of Treg cells have been identified as risk factors for CVD in patients with RA. Three nomograms combining various risk factors were constructed to predict CVD occurring in patients with RA (RA with/without CVD risk factors).

Indexed as

Arthritis, RheumatoidCardiovascular DiseasesAdultAgedFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAutoimmune diseaseCardiovascular diseaseRegulatory T cellsRheumatoid arthritisRisk factors

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.